glp-1 compounding news november 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding FDA Oversight of Compounded Drugs and Telehealth Providers FDA and Novo Nordisk Warned

The anti-aging skin claims are supported by in vitro, animal, and observational human data, which is consistent with what providers and patients report clinically

Dig Dis Sci (2002) 47(6):140512

Fujimoto J, Chow CW, Zhang J, Behrens C, Moran C, Little LD, Gumbs C, Antonoff MB, Vaporciyan AA, Swisher SG , Heymach JV, Lee JJ, Hong WK, Wistuba II, Futreal A

Additionally, rates of fresh cycle cancellation are higher, leading to compromised cumulative live birth rates ( 1.3 The established role of GLP-1 receptor agonists in obesity and T2D Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were originally introduced as therapeutic agents for T2D

It has shown promise as a treatment of erectile dysfunction and autism, among other conditions

Compounding, Sterility, and Product Quality Commercial NAD+ and glutathione injections are often compounded rather than supplied as FDA-approved finished drugs for wellness indications